Total Payments
$3,645
2024 Payments
$1,197
Companies
25
Transactions
251
Medicare Patients
7,720
Medicare Billing
$928,817
Payment Breakdown by Category
Food & Beverage$3,645 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,645 | 251 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $932.37 | 75 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $614.50 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $301.59 | 26 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $259.78 | 15 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $202.53 | 3 | $0 (2024) |
| Alcon Vision LLC | $201.74 | 11 | $0 (2024) |
| Oyster Point Pharma, Inc. | $200.80 | 18 | $0 (2024) |
| TISSUETECH, INC. | $139.81 | 5 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $135.45 | 10 | $0 (2022) |
| Allergan, Inc. | $124.40 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,197 | 73 | Bausch & Lomb Americas Inc. ($261.23) |
| 2023 | $948.45 | 70 | Bausch & Lomb Americas Inc. ($494.65) |
| 2022 | $627.41 | 51 | Bausch & Lomb Americas Inc. ($176.49) |
| 2021 | $385.71 | 28 | Kala Pharmaceuticals, Inc. ($95.31) |
| 2020 | $174.61 | 13 | Sun Pharmaceutical Industries Inc. ($55.40) |
| 2019 | $210.80 | 13 | TissueTech, Inc. ($64.46) |
| 2018 | $55.85 | 1 | TissueTech, Inc. ($55.85) |
| 2017 | $45.02 | 2 | Valeant Pharmaceuticals North America LLC ($45.02) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Ophthalmology | ||||||
| 12/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Ophthalmology | ||||||
| 12/29/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $74.22 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $49.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Dry eyes | ||||||
| 11/23/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $79.31 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/01/2024 | Alcon Vision LLC | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Ophthalmology | ||||||
| 11/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Ophthalmology | ||||||
| 10/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Ophthalmology | ||||||
| 10/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Ophthalmology | ||||||
| 09/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/27/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,407 | 3,437 | $1.2M | $298,004 |
| 2022 | 21 | 2,157 | 3,030 | $1.0M | $255,786 |
| 2021 | 23 | 2,388 | 3,329 | $1.2M | $300,978 |
| 2020 | 15 | 768 | 957 | $327,438 | $74,049 |
Total Patients
7,720
Total Services
10,753
Medicare Billing
$928,817
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67961 | Removal of up to 1/4 of eyelid margin and repair of eyelid | Office | 2023 | 46 | 76 | $182,400 | $39,245 | 21.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 254 | 329 | $115,150 | $33,739 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 269 | 470 | $94,000 | $33,103 | 35.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 81 | 191 | $180,000 | $33,004 | 18.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 228 | 391 | $117,300 | $30,542 | 26.0% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 62 | 115 | $115,000 | $23,480 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 177 | $53,100 | $16,346 | 30.8% |
| 92250 | Photography of the retina | Office | 2023 | 365 | 470 | $70,500 | $14,237 | 20.2% |
| 92134 | Imaging of retina | Office | 2023 | 306 | 421 | $52,625 | $14,037 | 26.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 34 | 45 | $54,000 | $12,101 | 22.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 188 | 219 | $38,325 | $11,205 | 29.2% |
| 67031 | Release of scar tissue between lens and retina using a laser | Office | 2023 | 12 | 28 | $25,200 | $9,478 | 37.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 15 | 79 | $34,400 | $8,500 | 24.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 169 | 201 | $25,125 | $5,850 | 23.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 48 | 48 | $16,800 | $5,613 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $15,200 | $4,322 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 23 | $3,450 | $1,036 | 30.0% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 38 | 39 | $3,900 | $921.38 | 23.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 18 | 19 | $3,420 | $707.46 | 20.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 58 | 58 | $2,900 | $538.56 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 308 | 647 | $129,400 | $47,330 | 36.6% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 94 | 204 | $231,720 | $37,523 | 16.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 275 | 350 | $122,500 | $34,169 | 27.9% |
| 67961 | Removal of up to 1/4 of eyelid margin and repair of eyelid | Office | 2022 | 47 | 55 | $136,800 | $29,430 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 190 | $57,100 | $19,572 | 34.3% |
About Dr. Bruce Kanengiser, M.D
Dr. Bruce Kanengiser, M.D is a Ophthalmology healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801956271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Kanengiser, M.D has received a total of $3,645 in payments from pharmaceutical and medical device companies, with $1,197 received in 2024. These payments were reported across 251 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,645).
As a Medicare-enrolled provider, Kanengiser has provided services to 7,720 Medicare beneficiaries, totaling 10,753 services with total Medicare billing of $928,817. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Piscataway, NJ
- Active Since 12/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801956271
Products in Payments
- VYZULTA (Drug) $601.92
- Cequa (Drug) $544.68
- XIIDRA (Drug) $467.65
- XDEMVY (Drug) $259.78
- DURYSTA (Drug) $206.40
- DAXXIFY (Drug) $202.53
- TYRVAYA (Drug) $200.80
- MIEBO (Drug) $186.38
- INVELTYS (Drug) $135.45
- Rocklatan (Drug) $125.85
- Prokera (Device) $124.63
- DOCTORS ALLERGY FORMULA (Device) $56.70
- EYLEA (Biological) $44.22
- BROMSITE (Drug) $41.77
- HYDRUS Microstent (Device) $33.19
- OXERVATE (Drug) $32.09
- Rhopressa (Drug) $32.05
- PROKERA (Device) $28.32
- LUMIGAN (Drug) $27.18
- rhopressa (Drug) $26.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.